Covid vaccine: CDC advisers weigh delaying second shot to eight weeks
Coronavirus vaccination: the most important questions and answers
Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK - BBC News
Evaluation of COVID-19 vaccination strategies with a delayed second dose | medRxiv
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults | Nature
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
Frontiers | COVID-19 Vaccination Does Not Affect Reproductive Health Parameters in Men
Cancer Patients Respond Poorly to First COVID mRNA Vax Dose | MedPage Today
Impfstoffe | KVWL - Corona
BioNTech-Pfizer wanted €54 per vaccine dose – DW – 02/18/2021
:format(jpeg)/cloudfront-us-east-1.images.arcpublishing.com/tgam/WPKJ4QULDRPQFH26FDKAD2IWYE.jpg "New study casts doubt on time between COVID-19 vaccine doses - The Globe and Mail")
New study casts doubt on time between COVID-19 vaccine doses - The Globe and Mail
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December
EU backs mix-and-match vaccines – DW – 12/07/2021
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR
Longer gap between Pfizer jabs boosts antibody response in elderly | Financial Times
FDA Authorizes 3rd Dose of Pfizer Vaccine for Immunocompromised Kids — Children's Cancer Cause
Which COVID-19 vaccine is right for you? – @theU
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM
Germany says it has been helping with Taiwan's BioNTech vaccine deal talks
Moderna, Pfizer-BioNTech vaccines have been approved in Canada. Here's what you need to know about them | CBC News
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
COVID-19 Vaccination in children
